- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GRI Bio Inc (GRI)GRI Bio Inc stock price live, this page displays NASDAQ GRI stock exchange data. View the GRI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GRI Bio Inc real time stock price chart below.
What Is the GRI Bio Inc Stock Price Today?
The GRI Bio Inc stock price today is 0.684.
What Is the Stock Symbol for GRI Bio Inc?
The stock symbol for GRI Bio Inc is "GRI."
What Stock Exchange Does GRI Bio Inc Trade On?
GRI Bio Inc is listed and trades on the NASDAQ stock exchange.
Is GRI Bio Inc a Good Stock to Buy?
Determining whether GRI Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRI quote. (ISIN: US3622AW3040)
What Is the GRI Bio Inc Stock Price Today?
The GRI Bio Inc stock price today is 0.684.
What Is the Stock Symbol for GRI Bio Inc?
The stock symbol for GRI Bio Inc is "GRI."
What Stock Exchange Does GRI Bio Inc Trade On?
GRI Bio Inc is listed and trades on the NASDAQ stock exchange.
Is GRI Bio Inc a Good Stock to Buy?
Determining whether GRI Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRI quote. (ISIN: US3622AW3040)
NASDAQ
Currency in USD
0.684
-0.077(-10.53%)
Closed
Pre Market
0.758+0.074(+10.82%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.670
0.756
52 wk Range
0.302
106.324
GRI Scorecard
Full Analysis
Management has been aggressively buying back shares
Unusual Pre-Market activity
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6700.756
52 wk Range
0.302106.324
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockGRI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
12.000
Upside
+1,654.386%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
GRI Bio Inc Company Profile
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase II clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company’s portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 for the treatment of primary sclerosing cholangitis, and GRI-0729, which are in pre-clinical development. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
Compare GRI to Peers and Sector
Metrics to compare | GRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −4.1x | −0.7x | |
PEG Ratio | −0.01 | −0.04 | 0.00 | |
Price/Book | 1.7x | 4.2x | 2.6x | |
Price / LTM Sales | - | 1,214.6x | 3.2x | |
Upside (Analyst Target) | - | 157.6% | 44.5% | |
Fair Value Upside | Unlock | −8.5% | 6.6% | Unlock |
Analysts' Recommendations
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.000
(+1,654.39% Upside)
People Also Watch
FAQ
What Is the GRI Bio (GRI) Stock Price Today?
The GRI Bio stock price today is 0.684
What Stock Exchange Does GRI Bio Trade On?
GRI Bio is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for GRI Bio?
The stock symbol for GRI Bio is "GRI."
What Is the GRI Bio Market Cap?
As of today, GRI Bio market cap is 6.11M.
What is GRI Bio Earnings Per Share?
The GRI Bio EPS is -7.90.
From a Technical Analysis Perspective, Is GRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.